Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes.
Muskiet MHA, Tonneijck L, Smits MM, van Baar MJB, Kramer MHH, Hoorn EJ, Joles JA, van Raalte DH. Muskiet MHA, et al. Among authors: van baar mjb, van raalte dh. Nat Rev Nephrol. 2017 Oct;13(10):605-628. doi: 10.1038/nrneph.2017.123. Epub 2017 Sep 4. Nat Rev Nephrol. 2017. PMID: 28869249 Review.
Renal outcomes in CVOTs: keep calm and carry on.
Muskiet MHA, van Baar MJB, Scholtes RA, van Raalte DH. Muskiet MHA, et al. Among authors: van baar mjb, van raalte dh. Lancet Diabetes Endocrinol. 2018 Sep;6(9):674-676. doi: 10.1016/S2213-8587(18)30195-5. Epub 2018 Jun 21. Lancet Diabetes Endocrinol. 2018. PMID: 29937268 No abstract available.
GLP-1 receptor agonists, CKD, and eGFR trajectory.
van Baar MJB, van Raalte DH, Muskiet MHA. van Baar MJB, et al. Among authors: van raalte dh. Lancet Diabetes Endocrinol. 2018 Oct;6(10):764-765. doi: 10.1016/S2213-8587(18)30241-9. Lancet Diabetes Endocrinol. 2018. PMID: 30266180 No abstract available.
18 results